Insulin Pills Market is expected to grow at a CAGR of 24.64% through 2031
Increasing instances of diabetes are driving the growth
in the global insulin pills market in the forecast period, 2027-2031.
According to TechSci Research report, “Insulin
Pills Market - Global Industry Size, Share, Trends, Competition, Opportunity
and Forecast, 2021-2031”, the Global Insulin Pills Market will grow from USD 0.04 Billion in 2025 to USD 0.15 Billion by 2031 at a 24.64% CAGR. The increasing geriatric population suffering from Type 1 and Type 2 diabetes is further
driving the growth of the global insulin pills market in the upcoming five
years.
Moreover, the prevalence of extensive research and technological advances to formulate innovative pharmaceutical products as a treatment for diseases, as well as to contain the symptoms, is expected to drive the futuristic growth of the global insulin pills market in the next five years. Additionally, increasing
patient compliance toward oral administration of the diabetes drugs is expected
to aid the growth of the global insulin pills market in the next five years.
Also, increasing awareness and preferences toward using insulin pills instead of injections, along with the advantages of the insulin pills over injections, are substantiating the growth of the global insulin pills market in the forecast years, until 2026.
Although the higher cost of pharmaceuticals and dependency on the drug might hinder the growth of the global insulin pills market, initiatives by several market players that are already dominating the pharmaceutical sector may support the growth and reinstate the futuristic growth of the global insulin pills market in the forecast period, 2022-2026.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on "Global Insulin Pills Market"
https://www.techsciresearch.com/report/insulin-pills-market/8025.html
The global insulin pills market is segmented on the basis of form, type
of insulin, competitive landscape, and regional distribution. Based on form,
the market is further fragmented into tablet and capsule forms. Tablets are
anticipated to hold the largest revenue shares of the market in the upcoming
five years on the grounds of its easier administration when compared to capsule
forms of the drugs, and thus dominate the market segmentation too.
Moreover, the increasing number of children with diabetes is surging the demand for tablets since they are easier to digest for them and even for the administration. Furthermore, injections of insulin to the younger population are difficult and non-feasible; thus, oral insulin drugs are more preferred, thereby aiding the growth of the sub-segment and driving the growth of the global insulin pills market in the next five years.
Capsules are also expected to register significant growth in the next five years on account of the added advantage of the capsules, which deliver the drug directly into the target organ and protect the drug from the gastrointestinal tract. Oramed Pharmaceuticals
Inc. discovered a way to convert injectable medications into oral treatments,
culminating in a breakthrough technology which protects the peptide as it
enters the gastrointestinal tract with a special coating, while pharmacology
(protease inhibitors) stops protein-degrading gut enzymes from damaging the
drug.
Additionally, absorption enhancers help the peptides cross the small
intestine wall. These functions that are feasible due to capsules are actively influencing the future growth of the global insulin pill
market in the forecast years.
List of major market players of the global insulin pills market includes:
- Novo Nordisk A/S
- Eli Lilly and Company
- Sanofi S.A.
- Biocon Limited
- Wockhardt Limited
- Gulf Pharmaceutical Industries
- Tonghua Dongbao Pharmaceutical Co., Ltd.
- B. Braun Melsungen AG
- Pfizer Inc.
- Ypsomed AG
Download Sample Report @
https://www.techsciresearch.com/sample-report.aspx?cid=8025
Customers can also request
for 10% free customization on this report.
The North America region is anticipated to dominate the regional market analysis in the upcoming five years on the grounds of the increasing number of patients suffering from abnormal blood sugar levels. Moreover, countries like United States and Canada in the
North America region have a well-established healthcare sector that is a major
factor influencing the growth of the market. Also, increasing development of innovative pharmaceuticals to combat blood sugar disorders is further substantiating the growth of the global insulin pill market in the next five years. Market players like Oramed Pharmaceutical Inc. are conducting a number of
clinical trials for the ORMD-0801 drug as an insulin pill and its approaching
approvals from the US-FDA show a probable increasing number of pharmaceutical
products that are expected to be launched and commercialized in next few years,
further aiding to the growth of the global insulin pill market in the forecast
years. New market players may form mergers and acquisitions with the established market players and dominators of the pharmaceutical industry, thus establishing their brand value in the market,” said Mr Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“Insulin Pills Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, Segmented By Form (Tablet v/s Capsule), By Type of Insulin (Long-Acting Insulin, Short-Acting Insulin, Rapid-Acting Insulin), By Region 2021-2031F”,
has evaluated the future growth potential of global insulin pills and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers, challenges,
and opportunities in global insulin pills market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/